Evidence map›Paper›PMID 28137862›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

DYRK1A regulates Hap1-Dcaf7/WDR68 binding with implication for delayed growth in Down syndrome.

Jianxing Xiang, Su Yang, Ning Xin, Marta A Gaertig, Roger H Reeves, Shihua Li, Xiao-Jiang Li

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Huntingtin Interacting Proteins and Pathological Implications.International journal of molecular sciences · 2023
    Review
  7. The Omnipresence of DYRK1A in Human Diseases.International journal of molecular sciences · 2022
    Review
  8. Genes · 2021
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jianxing XiangDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322.
Su YangDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322.
Ning XinDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322.
Marta A GaertigDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322.
Roger H ReevesDepartment of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Shihua LiDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322; xli2@emory.edu sli@emory.edu.
Xiao-Jiang LiDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322; xli2@emory.edu sli@emory.edu.
Emory University · USJohns Hopkins Medicine · US

Funding

GENOMIC APPROACHES TO ANEUPLOIDYR01HD038384 · NICHD · JOHNS HOPKINS UNIVERSITY · PI REEVES, ROGER H · 2000 to 2020
$11.0M
Translational Neuroscience CoreU54HD079123 · NICHD · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI FATEMI, S. ALI, SCHLAGGAR, BRADLEY L · 2014 to 2019
$7.9M
Neuronal function of huntingtin-associated proteinR01NS036232 · NINDS · EMORY UNIVERSITY · PI ESCAYG, ANDREW P · 1998 to 2021
$6.7M
N-terminal huntingtin and Huntington disease neuropathologyR01NS101701 · NINDS · EMORY UNIVERSITY · PI ESCAYG, ANDREW P · 2017 to 2021
$2.2M
Glial huntingtin and neurodegenerationR01NS095181 · NINDS · EMORY UNIVERSITY · PI WEINSHENKER, DAVID · 2015 to 2019
$1.7M
Polyglutamine Expansion Length Dependent PathologyR01NS095279 · NINDS · EMORY UNIVERSITY · PI WARREN, STEPHEN T. · 2015 to 2019
$1.7M
Glial huntingtin and neuronal excitotoxicityR01AG031153 · NIA · EMORY UNIVERSITY · PI LI, SHI-HUA · 2009 to 2013
$1.5M
NIA NIH HHS R01 AG031153NICHD NIH HHS R01 HD038384NICHD NIH HHS U54 HD079123NINDS NIH HHS R01 NS036232NINDS NIH HHS R01 NS095181NINDS NIH HHS R01 NS095279NINDS NIH HHS R01 NS101701
6 · The paper itself

Abstract

Huntingtin-associated protein 1 (Hap1) is known to be critical for postnatal hypothalamic function and growth. Hap1 forms stigmoid bodies (SBs), unique neuronal cytoplasmic inclusions of unknown function that are enriched in hypothalamic neurons. Here we developed a simple strategy to isolate the SB-enriched fraction from mouse brain. By analyzing Hap1 immunoprecipitants from this fraction, we identified a Hap1-interacting SB component, DDB1 and CUL4 associated factor 7 (Dcaf7)/WD40 repeat 68 (WDR68), whose protein level and nuclear translocation are regulated by Hap1. Moreover, we found that Hap1 bound Dcaf7 competitively in cytoplasm with dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A), a protein implicated in Down syndrome (DS). Depleting Hap1 promoted the DYRK1A-Dcaf7 interaction and increased the DYRK1A protein level. Transgenic DS mice overexpressing DYRK1A showed reduced Hap1-Dcaf7 association in the hypothalamus. Furthermore, the overexpression of DYRK1A in the hypothalamus led to delayed growth in postnatal mice, suggesting that DYRK1A regulates the Hap1-Dcaf7 interaction and postnatal growth and that targeting Hap1 or Dcaf7 could ameliorate growth retardation in DS.

Indexed as

Active Transport, Cell NucleusAdaptor Proteins, Signal TransducingAnimalsCell NucleusDown SyndromeDyrk KinasesHEK293 CellsHumansHypothalamusInclusion BodiesMice, KnockoutMice, TransgenicNerve Tissue ProteinsNeuronsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesAdaptor Proteins, Signal TransducingDcaf7 protein, mouseDyrk KinasesHap1 protein, mouseNerve Tissue ProteinsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesDcaf7Down syndromeDYRK1AHap1WDR68

Identifiers

PMID28137862
PMCPMC5321030
OpenAlexW2580835880

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.